skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines cipaglucosidase alfaQuestion & answer

cipaglucosidase alfa · Medicine question

By what route is cipaglucosidase alfa administered?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Cipaglucosidase alfa is administered by intravenous infusion.

Sources for this answer

Pombiliti 105 mg powder for concentrate for solution for infusionAmicus Therapeutics UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated 21 January 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

cipaglucosidase alfa

More questions about cipaglucosidase alfa

Can cipaglucosidase alfa cause serious allergic reactions during or after infusion?How does cipaglucosidase alfa replace the enzyme missing in Pompe disease?How long is reliable contraception required for women receiving cipaglucosidase alfa with miglustat?How much sodium does each vial of Pombiliti (cipaglucosidase alfa) contain?Is cipaglucosidase alfa in combination with miglustat recommended during pregnancy?

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the cipaglucosidase alfa guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX

Is cipaglucosidase alfa likely to have cytochrome P450- or P-glycoprotein-mediated interactions with other medicines?